PTO Form 1478 (Rev 9/2006)
`
`OMB No. 0651-0009 (Exp 12/31/2014)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 85861505
`Filing Date: 02/27/2013
`
`The table below presents the data as entered.
`
`Entered
`
`85861505
`
`DAZLUM
`
`YES
`
`YES
`
`DAZLUM
`
`The mark consists of standard characters, without claim to any particular font,
`style, size, or color.
`
`Principal
`
`Input Field
`
`SERIAL NUMBER
`
`MARK INFORMATION
`
`*MARK
`
`STANDARD CHARACTERS
`
`USPTO-GENERATED IMAGE
`
`LITERAL ELEMENT
`
`MARK STATEMENT
`
`REGISTER
`
`APPLICANT INFORMATION
`
`*OWNER OF MARK
`
`Millennium Pharmaceuticals, Inc.
`
`*STREET
`
`*CITY
`
`*STATE
`(Required for U.S. applicants)
`
`*COUNTRY
`
`*ZIP/POSTAL CODE
`(Required for U.S. applicants only)
`
`LEGAL ENTITY INFORMATION
`
`TYPE
`
`STATE/COUNTRY OF INCORPORATION
`
`40 Landsdowne Street
`
`Cambridge
`
`Massachusetts
`
`United States
`
`02139
`
`corporation
`
`Delaware
`
`GOODS AND/OR SERVICES AND BASIS INFORMATION
`
`INTERNATIONAL CLASS
`
`005(cid:160)
`
`*IDENTIFICATION
`
`FILING BASIS
`
`ATTORNEY INFORMATION
`
`NAME
`
`ATTORNEY DOCKET NUMBER
`
`FIRM NAME
`
`STREET
`
`Pharmaceutical preparations for the prevention and treatment of cancer;
`pharmaceutical preparations for the treatment of auto-immune diseases and
`disorders and inflammatory diseases and disorders
`
`SECTION 1(b)
`
`David Ehrlich
`
`MILL 1301797
`
`Fross Zelnick Lehrman & Zissu, P.C.
`
`866 United Nations Plaza
`
`

`

`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`CORRESPONDENCE INFORMATION
`
`NAME
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`FEE INFORMATION
`
`NUMBER OF CLASSES
`
`FEE PER CLASS
`
`*TOTAL FEE DUE
`
`*TOTAL FEE PAID
`
`SIGNATURE INFORMATION
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)ORIGINAL PDF FILE
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)CONVERTED PDF FILE(S)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(2 pages)
`
`SIGNATORY'S NAME
`
`SIGNATORY'S POSITION
`
`New York
`
`New York
`
`United States
`
`10017
`
`212 813 5900
`
`David Ehrlich
`
`Fross Zelnick Lehrman & Zissu, P.C.
`
`866 United Nations Plaza
`
`New York
`
`New York
`
`United States
`
`10017
`
`212 813 5900
`
`1
`
`325
`
`325
`
`325
`
`hw_6547140130-101335000_._DAZLUM_-
`_signed_application__F1179583_.PDF
`
`\\TICRS\EXPORT16\IMAGEOUT16\858\615\85861505\xml1\APP0003.JPG
`
`\\TICRS\EXPORT16\IMAGEOUT16\858\615\85861505\xml1\APP0004.JPG
`
`James D. Darnley, Jr.
`
`Vice President, Chief IP Counsel
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`

`

`PTO Form 1478 (Rev 9/2006)
`
`OMB No. 0651-0009 (Exp 12/31/2014)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 85861505
`Filing Date: 02/27/2013
`
`To the Commissioner for Trademarks:
`
`MARK:(cid:160)DAZLUM(cid:160)(Standard Characters, see mark)
`The literal element of the mark consists of DAZLUM.
`The mark consists of standard characters, without claim to any particular font, style, size, or color.
`
`The applicant, Millennium Pharmaceuticals, Inc., a corporation of Delaware, having an address of
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)40 Landsdowne Street
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Cambridge, Massachusetts 02139
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`
`requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register
`established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) International Class 005: (cid:160)Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the
`treatment of auto-immune diseases and disorders and inflammatory diseases and disorders
`Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on
`or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).
`
`The applicant's current Attorney Information:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)David Ehrlich of Fross Zelnick Lehrman & Zissu, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)866 United Nations Plaza
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10017
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`The attorney docket/reference number is MILL 1301797.
`The applicant's current Correspondence Information:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)David Ehrlich
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Fross Zelnick Lehrman & Zissu, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)866 United Nations Plaza
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10017
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)212 813 5900(phone)
`
`A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).
`
`Declaration
`
`The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under
`18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting
`registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be
`the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she
`believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or
`association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely,
`when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all
`statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
`
`Declaration Signature
`
`Signature: Not Provided (cid:160)(cid:160)(cid:160)Date: Not Provided
`Signatory's Name: James D. Darnley, Jr.
`
`

`

`Signatory's Position: Vice President, Chief IP Counsel
`RAM Sale Number: 85861505
`RAM Accounting Date: 02/27/2013
`
`Serial Number: 85861505
`Internet Transmission Date: Wed Feb 27 12:59:39 EST 2013
`TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2013022712593993
`5449-85861505-50071dba8e67311fd16f19f715
`96cdec63070f8a52cad9e9398974d6085311e579
`9-DA-13148-20130227125828099248
`
`

`

`DAZLUM
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFICE
`APPLICATION FOR REGISTRATION OF A TRADEMARK
`
`MARK:
`
`DAZLUM
`
`CLASS:
`
`5
`
`APPLICANT:
`
`Millennium Pharmaceuticals, Inc.
`
`ADDRESS:
`
`40 Landsdowne Street, Cambridge, Massachusetts 02139 I
`
`ENTITY:
`
`a corporation organized and existing under the laws of Delaware
`
`OUR REF:
`
`MILL 1301797
`
`The above-identifiedaapplicant has a bona fide intention to use the above mark in
`commerce on or in connection with the following goods, and requests that said mark be
`registered in the United States Patent and Trademark Office on the Principal ‘Register
`established by the Act of July 5, 1946 under Section 1(b):
`
`Pharmaceutical preparations for the prevention and treatment of cancer;
`pharmaceutical preparations for the treatment of auto-immune diseases and
`disorders and inflammatory diseases and disorders
`
`The mark is in standard characters and no claim is made to any particular font style,
`T
`size or color.
`
`(Fl11SB30.l }
`
`

`

`ADDRESS FOR CORRESPONDENCE
`
`Applicant requests that all correspondence in connection with this application be
`directed to its attorneys, the law firm of Fross Zelnick Lehrrnan & Zissu, P.C., 866 United
`_ Nations Plaza, New York, New York 10017, Attention: David Ehrlich (Telephone 212-813-
`5900)
`
`INTENTION AS OF FILING DATE
`
`If this application is signed after the application filing date, the applicant verifies that it
`had a bona fide intention _to use the mark in commerce on or in connection with the goods
`listed in this application as of the application filing date.
`a
`
`DECLARATION
`
`The undersigned being hereby warned that willful false statements and the like so made
`are punishable by fine or imprisonment, or both, under 18 U.S.C. 1001, and that such willful
`false statements and the like may jeopardize the validity of the application or any resulting
`registration, declares that he/she is properly authorized to execute this application on behalf of
`the applicant; he/she believes the applicant to be the owner of the trademark or service mark
`sought to be registered, or, if the application is being filed under 15 U.S.C. l051(b), he/she
`believes applicant to be entitled to use such mark in commerce; to the best of his/her
`knowledge and belief no other person, firm, corporation, or association has the right to use the
`above identified mark in commerce, either in the identical form thereof or in such near
`resemblance thereto as to be likely, when used on or in connection with the goods or services
`of such other person, to cause confusion, or to cause mistake, or to deceive; and all statements
`made of his/her own knowledge are true and all statements made on infonnation and belief are
`believed to be true.
`
`Millennium Pharmaceuticals, Inc.
`
`(’
`
`[Signature]
`
`Name: James D. Darnley, Jr. p
`
`Title: Vice President Chief [P Counsel
`
`Date of signature: Februm 27, 2013
`
`{1=n1ss3o.1 3
`
`